Eledon Pharmaceuticals, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
ELDN on Nasdaq
Location
19800 Macarthur Blvd., Suite 250, Irvine, CA

Insiders trading volume in the past year

Eledon Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bvf Partners L P/Il 10%+ Owner $4.05M +$17.3M Oct 29, 2024
Gary A. Lyons Director $674K May 1, 2023
Walter Ogier Director May 1, 2023
David-Alexandre C. Gros Chief Executive Officer, Director Jun 13, 2024
Bryan Smith General Counsel, Corporate Sec Jun 13, 2024
June Lee Director May 1, 2023
Allan Kirk Director Oct 2, 2023
Paul Little Chief Financial Officer Jun 13, 2024
Jan Hillson Director May 1, 2023
Steven Perrin President, Director Jun 13, 2024
Keith Katkin Director May 1, 2023
John McBride Director May 1, 2023
James A. Robinson Jr. Director Oct 2, 2023

Recent Insider Transactions by Companies or Individuals for Eledon Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.